Lincoln Pharmaceuticals

Lincoln Pharmaceuticals Ltd Reports 16.70% Rise in Profit at Rs. 35.19 Crore

Exports sales (FOB) in Q2FY21 increased 9.65 % to Rs. 68.85 crore and is expected to get further boost once we start exports to Europe. Strategic growth initiatives, strong performance in the domestic and international markets, EU approval, new product approvals, better margin products along with operational efficiency are likely to contribute healthy growth and maximize value for all stakeholders in the near to medium term.